×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Eledon’s Antibody Aids First Gene-Edited, Pig-to-Human Kidney Transplant
BioSpace
Tegoprubart, Eledon Pharmaceuticals' experimental anti-CD40L antibody, was part of the immunosuppressive treatment regimen used following...
1 month ago
Will Eledon Pharmaceuticals (NASDAQ:ELDN) Spend Its Cash Wisely?
Yahoo Finance
Eledon Pharmaceuticals didn't record any revenue over the last year, indicating that it's an early stage company still developing its business.
4 months ago
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances ...
Tipranks
Eledon Pharmaceuticals, Inc. (ELDN) has disclosed a new risk, in the Share Price & Shareholder Rights category. Eledon Pharmaceuticals, Inc. faces a...
1 month ago
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
GlobeNewswire
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results ...
1 month ago
We Think Eledon Pharmaceuticals (NASDAQ:ELDN) Needs To Drive Business Growth Carefully
Simply Wall St
In the last year, Eledon Pharmaceuticals burned through US$40m, which is just about equal to its US$41m market cap. That suggests the company...
1 month ago
Eledon Pharma completes first pig-to-human kidney transplant using Tegoprubart
Mugglehead Magazine
In a groundbreaking development in the field of transplantation, Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) announced the successful use of...
1 month ago
Eledon stock gains after first pig-to-human kidney transplant (NASDAQ:ELDN)
Seeking Alpha
U.S. surgeons conducted the world's first successful transplant of a genetically edited pig kidney into a human at the Massachusetts...
1 month ago
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a ...
Yahoo Finance
Historic kidney xenotransplantation procedure conducted at Massachusetts General Hospital Tegoprubart administration has now been used...
1 month ago
Eledon doses first participant in BESTOW trial of tegoprubart
Clinical Trials Arena
Eledon has dosed the first participant in the Phase II BESTOW trial of tegoprubart to prevent organ rejection during kidney transplantation.
7 months ago
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
GlobeNewswire
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook · First half of 2024: Report updated interim clinical...
3 months ago